Abstract:Glaucoma is a progressive neuropathy characterized by loss of vision as a result of the death of retinal ganglion cells (RGCs). There are currently no effective neuroprotectants to treat this disorder. In this series of studies, we used LINGO-1 antagonists, Nogo-66 receptor (NgR1) antagonists, sNgR-Fc, and brain-derived neurotrophic factor (BDNF) to study the neuroprotection of RGCs in a rat glaucoma model with chronic ocular hypertension. LINGO-1 is a functional member of the NgR1/TROY and the P75 signaling complexes that prevent axonal regeneration by activating RhoA in the central nervous system (CNS). NgR1 mediates the inhibition of axonal regeneration in the presence of three myelin proteins including Nogo-A, myelin-associated glycoprotein, and oligodendrocyte myelin glycoprotein in the CNS. LINGO-1 was expressed in RGCs and increased after the induction of ocular hypertension. Blocking LINGO-1 function with LINGO-1 soluble protein, LINGO-1-Fc, and LINGO-1 mAb 1A7 significantly promoted RGC survival 2 and 4 weeks after the induction of ocular hypertension and also after optic nerve transection. LINGO-1 formed a receptor complex with TrkB and negatively regulated its activation in the retina after ocular hypertension injury. Blocking LINGO-1 function with LINGO-1-Fc or 1A7 upregulated TrkB phosphorylation after high intraocular pressure injury. BDNF antibody significantly blocked the neuroprotection of LINGO-1-Fc on RGC survival. Similarly, in combination with BDNF, LINGO-1-Fc provided significantly more protection to RGCs in the 4-week glaucoma animals. Thus, LINGO-1 antagonists protect RGCs by regulating the BDNF and TrkB signaling in glaucoma. NgR1 was expressed in RGCs and increased after the induction of ocular hypertension. There was synaptic degeneration of RGCs already detected in the early stage under the elevated intraocular pressure, which preceded cell death in the early stage. The upregulation of Nogo-A may be a possible mechanism of RGC death and synapse degeneration in glaucoma. Soluble (s) NgR-Fc significantly promoted RGC survival at 2 and 4 weeks after ocular hypertension and also after optic nerve transection. Furthermore, sNgR-Fc relieved synaptic degeneration at 5 days, and at 2 and 4 weeks. This suggests that there indeed may be an opportunity to rescue RGCs that are undergoing synaptic alteration, but not yet committed to die. These data suggest that the antagonists of LINGO-1 and NgR1 may provide an attractive therapeutic strategy to prevent the degeneration of RGCs and synapses in glaucoma.

LINGO-1-Fc Fusion Protein Prevents Apoptosis of Cerebellar Granule Neurons Induced by Low-potassium

LINGO-1-Fc Fusion Protein Prevents Apoptosis of Cerebellar Granule Neurons Induced by Low-potassium

Inactivation of Glycogen Synthase Kinase-3β and Up-regulation of LINGO-1 Are Involved in LINGO-1 Antagonist Regulated Survival of Cerebellar Granular Neurons

LINGO-1 Receptor Promotes Neuronal Apoptosis by Inhibiting WNK3 Kinase Activity

Lingo-1 Antagonist Promotes Functional Recovery and Axonal Sprouting after Spinal Cord Injury

Inhibition of the leucine-rich repeat protein LINGO-1 enhances survival, structure, and function of dopaminergic neurons in Parkinson's disease models

LINGO-1 Deficiency Promotes Nerve Regeneration Through Reduction of Cell Apoptosis, Inflammation, and Glial Scar after Spinal Cord Injury in Mice

Blocking Lingo-1 Function Promotes Retinal Ganglion Cell Survival Following Ocular Hypertension And Optic Nerve Transection

LINGO-1 Interacts with WNK1 to Regulate Nogo-induced Inhibition of Neurite Extension

Lingo-1 Antagonist Promotes Spinal Cord Remyelination and Axonal Integrity in Mog-Induced Experimental Autoimmune Encephalomyelitis

Protective Effect of Ligustilide Against Low Potassium Induced Apoptosis in Cultured Rat Cerebellar Granule Neurons

LINGO‐1 Negatively Regulates TrkB Phosphorylation after Ocular Hypertension

Anti-LINGO-1 antibody treatment alleviates cognitive deficits and promotes maturation of oligodendrocytes in the hippocampus of APP/PS1 mice

Blocking LINGO-1 in Vivo Reduces Degeneration and Enhances Regeneration of the Optic Nerve

Inhibition of the Leucine-Rich Repeat Protein Lingo-1 Enhances RGC Survival in Optic Nerve Injury

Title Blocking LINGO-1 in vivo reduces degeneration and enhancesregeneration of the optic nerve

Neuroprotection of Retinal Ganglion Cells in Glaucoma by Blocking Lingo-1 Function or Using A Nogo-66 Receptor Antagonist

The Protection Effects of YC-1 on Cultured Rat Cerebellar Granule Neurons#br#Against Apoptosis Induced by Low Potassium

Anti-LINGO-1 antibody ameliorates cognitive impairment, promotes adult hippocampal neurogenesis, and increases the abundance of CB1R-rich CCK-GABAergic interneurons in AD mice

Down-Expression of Pgc-1 Alpha Partially Mediated by Jnk/C-Jun Through Binding to Cre Site During Apoptotic Procedure in Cerebellar Granule Neurons

SP1-mediated upregulation of LINGO-1 promotes degeneration of retinal ganglion cells in optic nerve injury